These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8536345)

  • 1. Synthesis and antitumor activity of novel dolastatin 10 analogs.
    Miyazaki K; Kobayashi M; Natsume T; Gondo M; Mikami T; Sakakibara K; Tsukagoshi S
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1706-18. PubMed ID: 8536345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cytostatic properties of structure-simplified analogs of dolastatin 15.
    Hu MK; Huang WS
    J Pept Res; 1999 Dec; 54(6):460-7. PubMed ID: 10604591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications.
    Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Durkin KP; Boyd MR; Bai R; Hamel E; Schmidt JM; Chapuis JC
    Anticancer Drug Des; 1995 Oct; 10(7):529-44. PubMed ID: 7495477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and X-ray crystal structure of the dolabellaauricularia peptide dolastatin 18.
    Pettit GR; Hogan F; Herald DL
    J Org Chem; 2004 Jun; 69(12):4019-22. PubMed ID: 15176826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity.
    Bai R; Roach MC; Jayaram SK; Barkoczy J; Pettit GR; Ludueña RF; Hamel E
    Biochem Pharmacol; 1993 Apr; 45(7):1503-15. PubMed ID: 8471072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic agents 365. Dolastatin 10 SAR probes.
    Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
    Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of novel dolastatin 10 derivatives for versatile conjugations.
    Yokosaka S; Izawa A; Sakai C; Sakurada E; Morita Y; Nishio Y
    Bioorg Med Chem; 2018 May; 26(8):1643-1652. PubMed ID: 29454703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and structure of the human cancer cell growth inhibitory cyclodepsipeptide dolastatin 16.
    Pettit GR; Xu JP; Hogan F; Williams MD; Doubek DL; Schmidt JM; Cerny RL; Boyd MR
    J Nat Prod; 1997 Aug; 60(8):752-4. PubMed ID: 9287413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Dolastatin 15 mimetic peptoids.
    Schmitt J; Bernd M; Kutscher B; Kessler H
    Bioorg Med Chem Lett; 1998 Feb; 8(4):385-8. PubMed ID: 9871690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of chimeric structures derived from the cytotoxic natural compounds dolastatin 10 and dolastatin 15.
    Poncet J; Busquet M; Roux F; Pierré A; Atassi G; Jouin P
    J Med Chem; 1998 Apr; 41(9):1524-30. PubMed ID: 9554885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiproliferative activity of a cyclic analog of dolastatin 10.
    Poncet J; Hortala L; Busquet M; Guéritte-Voegelein F; Thoret S; Pierré A; Atassi G; Jouin P
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2855-8. PubMed ID: 9873636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor agents. V. Synthesis and antileukemic activity of E-ring-modified (RS)-camptothecin analogues.
    Ejima A; Terasawa H; Sugimori M; Ohsuki S; Matsumoto K; Kawato Y; Yasuoka M; Tagawa H
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):683-8. PubMed ID: 1611680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Evaluation of Dolastatin 10 Analogues Containing Heteroatoms on the Amino Acid Side Chains.
    Dugal-Tessier J; Barnscher SD; Kanai A; Mendelsohn BA
    J Nat Prod; 2017 Sep; 80(9):2484-2491. PubMed ID: 28885014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.
    Bai R; Friedman SJ; Pettit GR; Hamel E
    Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrimidoacridine derivatives as potential antitumor agents.
    Antonini I; Cola D; Martelli S; Cholody WM; Konopa J
    Farmaco; 1992; 47(7-8):1035-46. PubMed ID: 1445611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.
    Luesch H; Moore RE; Paul VJ; Mooberry SL; Corbett TH
    J Nat Prod; 2001 Jul; 64(7):907-10. PubMed ID: 11473421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyngbyastatin 1 and Ibu-epilyngbyastatin 1: synthesis, stereochemistry, and NMR line broadening.
    Bai R; Bates RB; Hamel E; Moore RE; Nakkiew P; Pettit GR; Sufi BA
    J Nat Prod; 2002 Dec; 65(12):1824-9. PubMed ID: 12502322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452.
    Luesch H; Yoshida WY; Moore RE; Paul VJ; Mooberry SL; Corbett TH
    J Nat Prod; 2002 Jan; 65(1):16-20. PubMed ID: 11809057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dolastatins, a family of promising antineoplastic agents.
    Poncet J
    Curr Pharm Des; 1999 Mar; 5(3):139-62. PubMed ID: 10066887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages.
    Harrigan GG; Yoshida WY; Moore RE; Nagle DG; Park PU; Biggs J; Paul VJ; Mooberry SL; Corbett TH; Valeriote FA
    J Nat Prod; 1998 Oct; 61(10):1221-5. PubMed ID: 9784156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.